Transaction · 0001662982-26-000006

Wang Xiaodong

Wang Xiaodong, DIR, reported an open-market or private sale at BeOne Medicines Ltd. involving 1260.000000 shares for an estimated $445078.24. Reported holdings after the transaction were 0.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
ONCBeOne Medicines Ltd.
Trade date
Oct 13, 2026
Filing date
Oct 15, 2026
View on SEC Insider profile
Estimated value-$445kShares × reported price
Shares traded1.26k$353.24 per share
Holdings after0Direct
% of reported position traded100%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,260 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ONC price since this filing

Daily closing prices, with the filing date and available return windows
ONC · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -7.4%1w ago -3.0%1d ago -6.3%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001662982-26-000006
American Depositary Shares
Transaction date
Oct 13, 2026
Filed Oct 15, 2026, 09:08 PM · 2d delay
Shares
1,260 sh
$353.24 per share
Estimated value
-$445k
Computed from shares × price
Holdings after
0 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther Yes
Footnotes & amended
  1. F1

    These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.

  2. F2

    These securities are held by Wang Investment LLC, of which 99% of the limited liability company interests are owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a tr…

  3. F3

    These securities are held by the spouse of the Reporting Person.

  4. F4

    Each American Depositary Share represents 13 Ordinary Shares.

  5. F5

    The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2026.

  6. F6

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.98 to $349.97, inclusive. The Reporting Person has provided to t…

  7. F7

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.98 to $350.97, inclusive. The Reporting Person has provided to t…

  8. F8

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.98 to $351.97, inclusive. The Reporting Person has provided to t…

  9. F9

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.99 to $352.95, inclusive. The Reporting Person has provided to t…

  10. F10

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.01 to $353.325, inclusive. The Reporting Person has provided to…

  11. F11

    The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

  12. F12

    These securities vest over a four-year period as follows: 25% on July 13, 2017, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject…

Original filing · 0001662982-26-000006
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ONC